(Q33381700)

22 February 2018

title

One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab (English)

1 reference

22 February 2018

Immune thrombocytopenic purpura

1 reference

1 reference

1 reference

4

James B Bussel

1 reference

22 February 2018

18

Ellis J Neufeld

1 reference

22 February 2018

Mignon L Loh

8

object named as

Mignon L Loh

1 reference

22 February 2018

Bertil Glader

10

object named as

Bertil E Glader

1 reference

22 February 2018

author name string

Brigitta U Mueller

1

1 reference

22 February 2018

Carolyn M Bennett

2

1 reference

22 February 2018

Henry A Feldman

3

1 reference

22 February 2018

Thomas C Abshire

5

1 reference

22 February 2018

Theodore B Moore

6

1 reference

22 February 2018

Hadi Sawaf

7

1 reference

22 February 2018

Zora R Rogers

9

1 reference

22 February 2018

Maggie C McCarthy

11

1 reference

22 February 2018

Donald H Mahoney

12

1 reference

22 February 2018

Thomas A Olson

13

1 reference

22 February 2018

Stephen A Feig

14

1 reference

22 February 2018

Adonis N Lorenzana

15

1 reference

22 February 2018

William C Mentzer

16

1 reference

22 February 2018

George R Buchanan

17

1 reference

22 February 2018

Pediatric Rituximab/ITP Study Group

19

1 reference

22 February 2018

Glaser Pediatric Research Network

20

1 reference

22 February 2018

publication date

1 February 2009

1 reference

22 February 2018

published in

Pediatric Blood Cancer

1 reference

22 February 2018

volume

52

1 reference

22 February 2018

issue

2

1 reference

22 February 2018

page(s)

259-262

1 reference

22 February 2018

Severe chronic refractory immune thrombocytopenic purpura during childhood: a survey of physician management

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Childhood immune thrombocytopenic purpura: diagnosis and management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Grading of hemorrhage in children with idiopathic thrombocytopenic purpura

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Intravenous gammaglobulin in refractory immune thrombocytopenic purpura: efficacy with or without concomitant steroid therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Cost-effectiveness of splenectomy versus intravenous gamma globulin in treatment of chronic immune thrombocytopenic purpura in childhood

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Rituximab for adolescents with haemophilia and high titre inhibitors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5752113

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

31 October 2018

1 reference

12 December 2020

Chronic immune thrombocytopentic purpura in children: assessment of rituximab treatment

1 reference

12 December 2020

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study

1 reference

12 December 2020

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases

1 reference

12 December 2020

Identifiers

DOI

10.1002/PBC.21757

1 reference

22 February 2018

PMC publication ID

5752113

1 reference

22 February 2018

PubMed publication ID

18937333

1 reference

22 February 2018